U.S. Embassy and Consulate in Nigeria

U.S. Embassy and Consulate in Nigeria


The Honourable Minister of State for Health, Dr. Adeleke Mamora, described establishing the National HIV Clinical Mentorship Program (NCMP) as a significant landmark achievement for the HIV response in Nigeria and to build capacity and support HIV treatment and care service providers in an integrated approach. He made the statement at the formal launch of the U.S. Government supported Program in Abuja on Thursday, December 9, 2021.

The Minister also stated that the Nigeria HIV response had grown significantly in the last five years and that the past two years have perhaps been the most remarkable because of the resilience shown by the Program despite the challenges of the COVID-19 pandemic. With over 1.6 million people living with HIV on treatment, the country is firmly on the path to achieve epidemic control.

According to Dr. Mamora, the HIV Mentorship Program is coming at an excellent moment, “a time when the prospect of achieving epidemic control has become a reality and a central part of the discourse.” After epidemic control is achieved, transitioning to a chronic HIV health care model will require PLHIVs to engage with the health care system in an ongoing relationship for the long term.

Earlier, the U.S. Ambassador to Nigeria, Mary Beth Leonard, said achieving and sustaining HIV epidemic control has been the end goal since the U.S.-Nigerian partnership on HIV began and this mentorship program will strengthen government ownership of the HIV program – at both national and state levels – thus safeguarding  sustained long-term epidemic control of HIV. In addition, this program will provide an opportunity for healthcare workers to receive practical training while providing HIV services, using the tried, true and tested methods of continuous quality improvement in line with the current Nigeria HIV national guidelines.

She said that by building local healthcare workers’ clinical and programmatic capacity over time, the U.S. Government supports developing a workforce that can lead, manage, and monitor the HIV/AIDS response from within its healthcare system. “To date, we have supported the recruitment, training, and deployment of 19 national mentors to specific facilities across Nigeria, with another 46 state-level clinical mentors soon to be deployed”.

Ambassador Leonard said the Program aligns with the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) key priority of strengthening the core capabilities of partner governments to autonomously lead, manage and monitor their own HIV response in an effective, equitable, and enduring manner.

The NCMP is  implemented by Nigeria’s Ministry of Health through the National AIDS and STI Control Program (NASCP) with support from the United States Centers for Disease Control and Prevention (US-CDC).  The Program will deploy National and State Clinical Mentors to support health workers at facility and community levels through several mechanisms, including site visits, case discussions, and virtual platforms.

Highlights of the launch included goodwill messages from the Global Fund, UNAIDS, NEPHWAN, and other stakeholders in the HIV response. In addition, the program Logo and the Nigeria HIV Clinical Mentorship Program Guidelines were unveiled.

Distributed by APO Group on behalf of U.S. Embassy and Consulate in Nigeria.

Send us your press releases to pressrelease.zawya@refinitiv.com


© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.